While a protective role is attributed to IL-22, likely produced by ILC3s, in innate and adaptive IBD models, expressions of INF-γ and IL-17 are believed to drive inflammation in innate IBD models (30). This evidence concerns the gene IL17A and inflammatory bowel disease.